Dr Reddy’s Custom Pharmaceutical Services: A Tailor-Made Breakthrough Strategy in Pharma Offshoring?

Ananthi Rajayya

Chapter 5 in Innovation in India, 2012, pp 74-89 from Palgrave Macmillan

Abstract: Abstract Overwhelmed by escalating pressures to reduce health care costs, elevated R&D budgets, diminishing numbers of new drugs as against leading blockbuster drugs going off-patent, coupled with numerous regulatory challenges in the West, global pharma companies were increasingly exploring low-cost options but highly skilled destinations for offshoring their pharmaceutical services in order to attain maximum efficiency and productivity. Consequently, in the race for survival, major pharma and biotech companies were seeking to keep hold of their drug discovery and portfolio management, while outsourcing their manufacturing and research processes, thus developing a cost-effective business model in the highly competitive arena and substantiating an ever-growing demand for contract research and contract manufacturing services.

Keywords: Business Model; Drug Discovery; Manufacturing Service; Generic Brand; Generic Player (search for similar items in EconPapers)
Date: 2012
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-1-137-26855-6_5

Ordering information: This item can be ordered from
http://www.palgrave.com/9781137268556

DOI: 10.1057/9781137268556_5

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().